People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

The average life expectancy of people diagnosed with dementia ranges from 9 years at age 60 to 4.5 years at age 85 for women ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...